MORGAN STANLEY - TALIS BIOMEDICAL CORP ownership

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of TALIS BIOMEDICAL CORP
ValueSharesWeighting
Q2 2023$29,691
-0.4%
61,857
+1.6%
0.00%
Q1 2023$29,820
+12.3%
60,857
+2.1%
0.00%
Q4 2022$26,561
-50.8%
59,595
-24.9%
0.00%
Q3 2022$54,000
-61.2%
79,376
-53.8%
0.00%
Q2 2022$139,000
-34.4%
171,652
+14.2%
0.00%
Q1 2022$212,000
-70.1%
150,297
-14.8%
0.00%
Q4 2021$708,000
-64.0%
176,334
-44.0%
0.00%
Q3 2021$1,966,000
-59.7%
314,614
-28.9%
0.00%
-100.0%
Q2 2021$4,878,000
+2097.3%
442,250
+2458.6%
0.00%
Q1 2021$222,00017,2850.00%
Other shareholders
TALIS BIOMEDICAL CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Greenlight Capital 1,569,300$6,293,0000.36%
ArrowMark Colorado Holdings LLC 4,915,239$19,710,0000.16%
Baker Brothers Advisors 7,624,835$30,576,0000.15%
Golden State Equity Partners 22,133$89,0000.04%
PRELUDE CAPITAL MANAGEMENT, LLC 188,269$755,0000.02%
PDT Partners, LLC 34,890$140,0000.01%
PERSONAL CFO SOLUTIONS, LLC 10,000$40,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 32,500$130,0000.00%
Qube Research & Technologies Ltd 59,161$237,0000.00%
TWO SIGMA INVESTMENTS, LP 78,628$315,0000.00%
View complete list of TALIS BIOMEDICAL CORP shareholders